Clear 591 Results Filter Filter Results Type: Press Release Abiomed Fourth Quarter Fiscal 2020 Earnings and Conference Call Notification Type: Press Release Abiomed’s Response to the COVID-19 Pandemic Type: Press Release Abiomed Announces Q3 FY 2020 Revenue of $222 Million and 317% Operating Margin Type: Press Release Abiomed Announces Preliminary Q3 FY 2020 Revenue of $222 Million up 10% Over Prior Year Type: Press Release Abiomed to Present at the 38th Annual JP Morgan Healthcare Conference Type: Press Release First Patient Enrolls in STEMI DTU Randomized Controlled FDA Trial Study Aims to Further Demonstrate Impella’s Safety and Effectiveness Type: Press Release Abiomed to Present at the 31st Annual Piper Jaffray Healthcare Conference Type: Press Release Abiomed Medical Office Completes Review of Observational Analysis of Impella Presented at AHA Type: Press Release Clinical Review Demonstrates Cost-Effectiveness of Impella in High-Risk PCI and Cardiogenic Shock Type: Press Release First US Patients Treated with Impella 55 with SmartAssist a Minimally Invasive Forward Flow Heart Pump 1 2 3 4 …
